Increasing L-homoserine production in Escherichia coli by engineering the central metabolic pathways.
Central metabolic pathways
Escherichia coli
Metabolic engineering
l-Homoserine
Journal
Journal of biotechnology
ISSN: 1873-4863
Titre abrégé: J Biotechnol
Pays: Netherlands
ID NLM: 8411927
Informations de publication
Date de publication:
20 May 2020
20 May 2020
Historique:
received:
15
10
2019
revised:
07
03
2020
accepted:
25
03
2020
pubmed:
7
4
2020
medline:
15
12
2020
entrez:
7
4
2020
Statut:
ppublish
Résumé
l-homoserine is an important functional amino acid. Based on the system metabolic engineering strategy, the key genes in the central metabolic pathway of Escherichia coli W3110 were engineered to construct the strain for l-homoserine production. To construct an engineered strain with high yield of l-homoserine, the work was carried out from the following aspects: (1) Disrupt the competitive and degradative pathways of l-homoserine, and the l-homoserine was initially accumulated with a titer of 0.2 g/L; (2) Exploring the effect of weakening TCA cycle, modification of the glyoxylate branch, and reduction of the pyruvate synthesis for l-homoserine synthesis. The concentration of l-homoserine in the final recombinant strain LJL12 reached a titer of 3.2 g/L at shake flask and 35.8 g/L in fed-batch fermentation, showing a high l-homoserine production capacity (0.82 g/L/h). The study provides a well research foundation for l-homoserine production with the capacity for industrial application.
Identifiants
pubmed: 32251699
pii: S0168-1656(20)30073-0
doi: 10.1016/j.jbiotec.2020.03.010
pii:
doi:
Substances chimiques
Escherichia coli Proteins
0
Homoserine
6KA95X0IVO
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-7Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None.